{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:08:56Z","timestamp":1787238536264,"version":"build-2736575974"},"reference-count":121,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.023","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T16:54:14Z","timestamp":1556038454000},"page":"3040-3049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Polio endgame: Lessons for the global rotavirus vaccination program"],"prefix":"10.1016","volume":"37","author":[{"given":"Baoming","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger I.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.023_b0005","series-title":"Immunological basis for immunization","first-page":"1","article-title":"Poliomyelitis","author":"Robertson","year":"2001"},{"key":"10.1016\/j.vaccine.2019.04.023_b0010","series-title":"Vaccines","first-page":"598","article-title":"Poliovirus vaccine - live","author":"Sutter","year":"2013"},{"issue":"9532","key":"10.1016\/j.vaccine.2019.04.023_b0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0140-6736(06)68815-6","article-title":"Rotavirus vaccines: current prospects and future challenges","volume":"368","author":"Glass","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0020","first-page":"252","article-title":"Problems with oral poliovaccine in India","volume":"9","author":"John","year":"1972","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2019.04.023_b0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0030","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1586\/erv.09.106","article-title":"Intussusception and rotavirus vaccination: a review of the available evidence","volume":"8","author":"Patel","year":"2009","journal-title":"Expert Rev Vacc"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.04.023_b0040","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.023_b0045","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease","volume":"14","author":"Strebel","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.04.023_b0050","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1086\/605035","article-title":"Oral rotavirus vaccines: how well will they work where they are needed most?","volume":"200","author":"Patel","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.023_b0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40272-018-0283-3","article-title":"Rotavirus vaccines: effectiveness, safety, and future directions","volume":"20","author":"Burnett","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0060","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"Patel","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"52","key":"10.1016\/j.vaccine.2019.04.023_b0065","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1016\/j.vaccine.2008.10.008","article-title":"Inactivated rotavirus vaccines: a priority for accelerated vaccine development","volume":"26","author":"Jiang","year":"2008","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2019.04.023_b0070","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.vaccine.2018.03.008","article-title":"The future control of rotavirus disease: can live oral vaccines alone solve the rotavirus problem?","volume":"36","author":"Glass","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.023_b0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1473-3099(17)30242-6","article-title":"Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial","volume":"17","author":"Groome","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"40","key":"10.1016\/j.vaccine.2019.04.023_b0080","first-page":"293","article-title":"Certification of poliomyelitis eradication-the Americas, 1994","volume":"69","author":"Expanded programme on immunization","year":"1994","journal-title":"Wkly Epidemiol Rec"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.023_b0085","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biologicals.2006.02.012","article-title":"Interrupting poliovirus transmission \u2013 new solutions to an old problem","volume":"34","author":"Aylward","year":"2006","journal-title":"Biologicals"},{"issue":"2822","key":"10.1016\/j.vaccine.2019.04.023_b0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.109.2822.85","article-title":"Cultivation of the lansing strain of poliomyelitis virus in cultures of various human embryonic tissues","volume":"109","author":"Enders","year":"1949","journal-title":"Science"},{"issue":"6199","key":"10.1016\/j.vaccine.2019.04.023_b0095","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Polio eradication. Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"issue":"5566","key":"10.1016\/j.vaccine.2019.04.023_b0100","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0105","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"5123","key":"10.1016\/j.vaccine.2019.04.023_b0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.1.5123.663","article-title":"Present position of immunization against poliomyelitis with live virus vaccines","volume":"1","author":"Sabin","year":"1959","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2105\/AJPH.44.5.563","article-title":"Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines","volume":"44","author":"Salk","year":"1954","journal-title":"Am J Public Health Nations Health"},{"issue":"8693","key":"10.1016\/j.vaccine.2019.04.023_b0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0140-6736(90)90945-2","article-title":"Polio vaccines: time for a change in immunisation policy?","volume":"335","author":"Beale","year":"1990","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.04.023_b0125","first-page":"129","article-title":"Methods for poliomyelitis eradication: is there a consensus?","volume":"21","author":"Beale","year":"1993","journal-title":"Public Health Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.023_b0130","first-page":"973","article-title":"Interrupting the transmission of wild polioviruses with vaccines: immunological considerations","volume":"72","author":"Ghendon","year":"1994","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.023_b0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1099-1654(199707)7:2<83::AID-RMV193>3.0.CO;2-Q","article-title":"Developed countries should not use inactivated polio vaccine for the prevention of poliomyelitis","volume":"7","author":"Henderson","year":"1997","journal-title":"Rev Med Virol"},{"issue":"5327","key":"10.1016\/j.vaccine.2019.04.023_b0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1126\/science.277.5327.780","article-title":"Ending polio immunization","volume":"277","author":"Hull","year":"1997","journal-title":"Science"},{"issue":"8909","key":"10.1016\/j.vaccine.2019.04.023_b0145","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(94)92472-4","article-title":"Paralytic poliomyelitis: seasoned strategies, disappearing disease","volume":"343","author":"Hull","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/oxfordjournals.aje.a112180","article-title":"Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection","volume":"102","author":"John","year":"1975","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0155","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a112181","article-title":"Oral polio vaccination of children in the tropics. III. Intercurrent enterovirus infections, vaccine virus take and antibody response","volume":"102","author":"John","year":"1975","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.023_b0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.aje.a121457","article-title":"Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference","volume":"96","author":"John","year":"1972","journal-title":"Am J Epidemiol"},{"issue":"8945","key":"10.1016\/j.vaccine.2019.04.023_b0165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(95)90305-4","article-title":"Polio eradication","volume":"345","author":"Ward","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.04.023_b0170","series-title":"Vaccine","first-page":"573","article-title":"Poliovirus vaccine - Inactivated","author":"Vidor","year":"2013"},{"key":"10.1016\/j.vaccine.2019.04.023_b0175","unstructured":"Available at <http:\/\/polioeradication.org\/polio-today\/polio-now\/wild-poliovirus-list\/> (Last accessed, 27 April 2018)."},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2019.04.023_b0180","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jix117","article-title":"Addressing the challenges and opportunities of the polio endgame: lessons for the future","volume":"216","author":"Patel","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.023_b0185","unstructured":"Available at <http:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/circulating-vaccine-derived-poliovirus\/> [Last accessed, 15 February 2017]."},{"key":"10.1016\/j.vaccine.2019.04.023_b0190","first-page":"1","article-title":"Polio endgame: the global switch from tOPV to bOPV","author":"Garon","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.023_b0195","first-page":"53","article-title":"A developing country perspective on vaccine-associated paralytic poliomyelitis","volume":"82","author":"John","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"5802","key":"10.1016\/j.vaccine.2019.04.023_b0200","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.023_b0205","first-page":"115","article-title":"Immunization in India with trivalent and monovalent oral poliovirus vaccines of enhanced potency","volume":"54","author":"John","year":"1976","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.023_b0210","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/jiu182","article-title":"Influence of enteric infections on response to oral poliovirus vaccine: a systematic review and meta-analysis","volume":"210","author":"Parker","year":"2014","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.023_b0215","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/jis241","article-title":"Waning intestinal immunity after vaccination with oral poliovirus vaccines in India","volume":"205","author":"Grassly","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.023_b0220","first-page":"29","article-title":"The cutter incident. Poliomyelitis following formaldehyde- inactivated poliovirus vaccination in the united states during the spring of 1955. ii. relationship of poliomyelitis to cutter vaccine","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2019.04.023_b0225","first-page":"16","article-title":"The cutter incident. poliomyelitis following formaldehyde- inactivated poliovirus vaccination in the United States during the spring of 1955. I. Background","volume":"78","author":"Nathanson","year":"1963","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2019.04.023_b0230","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.1961.03040100007003","article-title":"Standardization, licensing, and availability of live poliovirus vaccine","volume":"175","author":"Murray","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.04.023_b0235","first-page":"1325","article-title":"Paralytic poliomyelitis in Massachusetts","volume":"264","author":"Berkovich","year":"1959","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.023_b0240","first-page":"27","article-title":"Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line","volume":"70","author":"Montagnon","year":"1989","journal-title":"Dev Biol Stand"},{"issue":"8591","key":"10.1016\/j.vaccine.2019.04.023_b0245","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(88)91711-4","article-title":"Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine","volume":"1","author":"Robertson","year":"1988","journal-title":"Lancet"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2019.04.023_b0250","first-page":"489","article-title":"Successful control of poliomyelitis by a combined OPV\/IPV polio vaccine program in the West Bank and Gaza, 1978\u201393","volume":"30","author":"Tulchinsky","year":"1994","journal-title":"Isr J Med Sci"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2019.04.023_b0255","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2011.10.005","article-title":"The global polio eradication initiative: lessons learned and prospects for success","volume":"29","author":"Aylward","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.023_b0260","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.coviro.2013.05.007","article-title":"Poliovirus vaccination options for achieving eradication and securing the endgame","volume":"3","author":"Estivariz","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.023_b0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1574-695X.2009.00621.x","article-title":"Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary","volume":"58","author":"Kapusinszky","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.04.023_b0270","unstructured":"World Health Organization. Scientific evidence in support of: 5th Meeting of the SAGE Working Group, WHO, Geneva, September 3-4, 2012. Available at: <http:\/\/www.who.int\/immunization\/sage\/meetings\/2012\/november\/3__SAGE_WG_Scientific_Evidence22Oct2012.pdf> [Last accessed June 26, 2014]."},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.023_b0275","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"8860","key":"10.1016\/j.vaccine.2019.04.023_b0280","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0140-6736(93)90693-B","article-title":"Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine","volume":"341","author":"Moriniere","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.023_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/163.1.1","article-title":"Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines","volume":"163","author":"Onorato","year":"1991","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.023_b0290","doi-asserted-by":"crossref","first-page":"e1002599","DOI":"10.1371\/journal.ppat.1002599","article-title":"Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge","volume":"8","author":"Hird","year":"2012","journal-title":"PLoS Pathog"},{"issue":"9953","key":"10.1016\/j.vaccine.2019.04.023_b0295","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.04.023_b0300","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.cmi.2016.06.018","article-title":"Public health response to the silent reintroduction of wild poliovirus to Israel, 2013\u20132014","volume":"22","author":"Moran-Gilad","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2019.04.023_b0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jcv.2015.03.005","article-title":"Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel","volume":"66","author":"Moran-Gilad","year":"2015","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.023_b0310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.vaccine.2015.11.066","article-title":"How many OPV rounds are required to stop wild polio virus circulation in a developed country?. Lessons from the Israeli experience","volume":"34","author":"Tasher","year":"2016","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2019.04.023_b0315","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1056\/NEJMoa054960","article-title":"placebo-controlled trial of inactivated poliovirus vaccine in Cuba","volume":"356","author":"Randomized","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.023_b0320","unstructured":"World Health Organization unpublished data, presented <http:\/\/www.who.int\/immunization\/sage\/meetings\/2012\/november\/3__SAGE_WG_Scientific_Evidence22Oct2012.pdf>."},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0325","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/cdli.4.5.499-503.1997","article-title":"Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands","volume":"4","author":"Herremans","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.04.023_b0330","unstructured":"Meeting of the Strategic Advisory Group of Experts on Immunization, April 2012 \u2013 conclusions and recommendations. Wkly Epidemiol Rec 2012; 87(21): 201\u201316."},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.023_b0335","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMp1514467","article-title":"A world free of polio-the final steps","volume":"374","author":"Patel","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.023_b0340","unstructured":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2017 \u2013 conclusions and recommendations. Wkly Epidemiol Rec 2017; 92(22): 301\u201320."},{"issue":"9","key":"10.1016\/j.vaccine.2019.04.023_b0345","doi-asserted-by":"crossref","first-page":"e0183392","DOI":"10.1371\/journal.pone.0183392","article-title":"Estimating global, regional and national rotavirus deaths in children aged <5 years: current approaches, new analyses and proposed improvements","volume":"12","author":"Clark","year":"2017","journal-title":"PLoS ONE"},{"issue":"20","key":"10.1016\/j.vaccine.2019.04.023_b0350","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJM197311152892025","article-title":"Letter: Evidence for viral gastroenteritis","volume":"289","author":"Bishop","year":"1973","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0355","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/01.inf.0000186295.18969.e6","article-title":"Update on rotavirus vaccines","volume":"24","author":"Bresee","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.04.023_b0360","first-page":"6","article-title":"Performance of rotavirus vaccines in developed and developing countries","author":"Jiang","year":"2010","journal-title":"Hum Vaccin"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0365","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/infdis\/jix186","article-title":"Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea","volume":"215","author":"Burnett","year":"2017","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.023_b0370","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1473-3099(12)70029-4","article-title":"Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?","volume":"12","author":"Patel","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1 Suppl","key":"10.1016\/j.vaccine.2019.04.023_b0375","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/INF.0b013e3181fefa1f","article-title":"Real-world impact of rotavirus vaccination","volume":"30","author":"Patel","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"47","key":"10.1016\/j.vaccine.2019.04.023_b0380","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1016\/j.vaccine.2018.01.058","article-title":"Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo","volume":"36","author":"Tsolenyanu","year":"2018","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2019.04.023_b0385","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1016\/j.vaccine.2017.12.056","article-title":"Impact and effectiveness of pentavalent rotavirus vaccine in children <5years of age in Burkina Faso","volume":"36","author":"Bonkoungou","year":"2018","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.04.023_b0390","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1093\/cid\/civ1210","article-title":"Impact of rotavirus vaccination on hospitalizations and deaths from childhood gastroenteritis in Botswana","volume":"62","author":"Enane","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.04.023_b0395","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/cid\/civ1207","article-title":"Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: a multisite prospective case-control study","volume":"62","author":"Gastanaduy","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.023_b0400","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1473-3099(14)71060-6","article-title":"Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study","volume":"15","author":"Bar-Zeev","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.023_b0405","doi-asserted-by":"crossref","first-page":"e1001024","DOI":"10.1371\/journal.pmed.1001024","article-title":"Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis","volume":"8","author":"Do Carmo","year":"2011","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.023_b0410","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa0905211","article-title":"Effect of rotavirus vaccination on death from childhood diarrhea in Mexico","volume":"362","author":"Richardson","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.023_b0415","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1056\/NEJMc1100062","article-title":"Childhood diarrhea deaths after rotavirus vaccination in Mexico","volume":"365","author":"Richardson","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2019.04.023_b0420","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/infdis\/jir492","article-title":"Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States","volume":"204","author":"Lopman","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.023_b0425","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1097\/INF.0b013e31827d3b68","article-title":"Global seasonality of rotavirus disease","volume":"32","author":"Patel","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.04.023_b0430","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2011.0062","article-title":"Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence","author":"Pitzer","year":"2011","journal-title":"J R Soc Interface"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.04.023_b0435","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1086\/431499","article-title":"Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs","volume":"192","author":"Gentsch","year":"2005","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.04.023_b0440","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"World health organization-coordinated global rotavirus surveillance N. global, regional, and national estimates of rotavirus mortality in children <5 Years of Age, 2000\u20132013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2019.04.023_b0445","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.vaccine.2005.12.048","article-title":"Immunity and correlates of protection for rotavirus vaccines","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.023_b0450","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1086\/340103","article-title":"The role of serum antibodies in the protection against rotavirus disease: an overview","volume":"34","author":"Jiang","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2019.04.023_b0455","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.2009.756","article-title":"Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua","volume":"301","author":"Patel","year":"2009","journal-title":"JAMA"},{"issue":"9741","key":"10.1016\/j.vaccine.2019.04.023_b0460","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.023_b0465","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger","volume":"376","author":"Isanaka","year":"2017","journal-title":"N Engl J Med"},{"issue":"9935","key":"10.1016\/j.vaccine.2019.04.023_b0470","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial","volume":"383","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"issue":"9741","key":"10.1016\/j.vaccine.2019.04.023_b0475","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.023_b0480","first-page":"145","article-title":"Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors","volume":"17","author":"Velasquez","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.04.023_b0485","first-page":"1","article-title":"Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries?","author":"Steele","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.04.023_b0490","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.cmi.2016.03.007","article-title":"Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines","volume":"22","author":"Aliabadi","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.023_b0495","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/cid\/cis191","article-title":"Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America","volume":"54","author":"Desai","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2019.04.023_b0500","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.023_b0505","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.023_b0510","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.023_b0515","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.vaccine.2019.04.023_b0520","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1713909","article-title":"Evaluation of intussusception after monovalent rotavirus vaccination in Africa","volume":"378","author":"Tate","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0525","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1586\/14760584.2014.942223","article-title":"Intussusception following rotavirus vaccination: an updated review of the available evidence","volume":"13","author":"Rha","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.023_b0530","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1303164","article-title":"Intussusception risk after rotavirus vaccination in U.S. infants","volume":"370","author":"Yih","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.023_b0535","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.023_b0540","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1311738","article-title":"Risk of intussusception after monovalent rotavirus vaccination","volume":"370","author":"Weintraub","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.04.023_b0545","article-title":"Approaches to monitoring intussusception following rotavirus vaccination","author":"Tate","year":"2018","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0550","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3201\/eid1911.121407","article-title":"Evidence of vaccine-related reassortment of rotavirus, Brazil, 2008\u20132010","volume":"19","author":"Rose","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0555","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1586\/erv.12.114","article-title":"Rotavirus vaccine-derived shedding and viral reassortants","volume":"11","author":"Bowen","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.023_b0560","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jama.2010.863","article-title":"FDA: Benefits of rotavirus vaccination outweigh potential contamination risk","volume":"304","author":"Kuehn","year":"2010","journal-title":"JAMA"},{"issue":"46","key":"10.1016\/j.vaccine.2019.04.023_b0565","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1016\/j.vaccine.2011.07.123","article-title":"Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines","volume":"29","author":"Ma","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.023_b0570","first-page":"6(3)","article-title":"Molecular characterization of human rotavirus vaccine strain CDC-9 during sequential passages in Vero cells","author":"Esona","year":"2010","journal-title":"Hum Vaccin"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.023_b0575","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4161\/hv.24958","article-title":"Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies","volume":"9","author":"Jiang","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.023_b0580","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41598-017-18973-9","article-title":"Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice","volume":"8","author":"Resch","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.023_b0585","doi-asserted-by":"crossref","first-page":"e0166038","DOI":"10.1371\/journal.pone.0166038","article-title":"Skin vaccination against rotavirus using microneedles: proof of concept in gnotobiotic piglets","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS ONE"},{"issue":"33","key":"10.1016\/j.vaccine.2019.04.023_b0590","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.vaccine.2010.06.006","article-title":"Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.023_b0595","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.vaccine.2018.12.043","article-title":"Lack of immune interference between inactivated polio vaccine and inactivated rotavirus vaccine co-administered by intramuscular injection in two animal species","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.023_b0600","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix054","article-title":"Administering Multiple Injectable Vaccines - Summary of findings from the accelerated introduction of inactivated polio vaccine globally","author":"Dolan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.023_b9000","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(14)70832-1","article-title":"Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis","volume":"14","author":"Leshem","year":"2014","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:12Z","timestamp":1759401132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19304748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":121,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19304748"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polio endgame: Lessons for the global rotavirus vaccination program","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}